Shares of Translational Development Acquisition Corp. (NASDAQ:TDACU – Get Free Report) dropped 2.6% on Thursday . The stock traded as low as $11.55 and last traded at $11.70. Approximately 102 shares changed hands during trading, a decline of 95% from the average daily volume of 2,253 shares. The stock had previously closed at $12.01.
Translational Development Acquisition Trading Down 2.6%
The stock has a fifty day moving average price of $11.76 and a two-hundred day moving average price of $10.96.
About Translational Development Acquisition
Translational Development Acquisition Corp. is a blank check acquisition company incorporated in Delaware. The company was formed to effect a merger, stock purchase, asset acquisition, stock exchange, reorganization or similar business combination with one or more businesses, though it has not yet identified a target for its initial transaction.
In early 2021, the company completed its initial public offering and listed its units on the Nasdaq under the ticker TDACU. Each unit comprises one Class A ordinary share and one-third of a warrant to purchase additional Class A shares, with its securities also trading separately as shares and warrants.
Following its IPO, the net proceeds from the offering are held in a trust account until the closing of an initial business combination.
Recommended Stories
- Five stocks we like better than Translational Development Acquisition
- Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street
- Revving Up Returns: Big Banks Race Through the Rate Plateau
- Why Uber’s Biggest Deal Yet Could Unlock Its Next Growth Phase
- Why Microsoft Is Playing a Different AI Game Than Big Tech—and Cash Flow Is the Test
Receive News & Ratings for Translational Development Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Translational Development Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
